RAPPRapport Therapeutics, Inc.

$52.44

What is the market doing?

What the tape says about RAPP

Rapport Therapeutics, Inc. is +240% over the past year while the S&P 500 is +23%: 218 points ahead of the market.

+240%

1-year return · S&P 500 +23%

vs 200-day average
+58%

vs 200-day average · a clear uptrend

RSI (14)
73

RSI (14) · overbought, bought harder than it has been sold

Below its 52-week high
0.00%

Below its 52-week high

2024-08-06$7.15 – $52.44 · dashed line: 200-day average2026-08-26
Details
Last close2026-08-26
$52.44
1 monthS&P 500 +3.7%
+27%
1 yearS&P 500 +23%
+240%
vs 50-day average$41.97
+25%
52-week high
$52.44
52-week low
$14.24
Annualised volatility
121%
Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
−$341K
Calendar-year price return
YearReturn
2026 (year to date)+73%
2025+71%
Average return by calendar month, 2024–2026
MonthYearsPositiveAverage
Jan20 of 2−9.9%
Feb21 of 2−15%
Mar21 of 2+3.9%
Apr22 of 2+10%
May21 of 2−4.3%
Jun21 of 2+18%
Jul32 of 3+11%
Aug32 of 3+15%
Sep21 of 2+31%
Oct21 of 2+8.6%
Nov21 of 2−2.1%
Dec21 of 2−10%

End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.